Asymmetrical Gait Training After Pediatric Stroke

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Completed
CT.gov ID
NCT01827436
Collaborator
(none)
9
1
2
44
0.2

Study Details

Study Description

Brief Summary

The purposes of this pilot research study are 1. To begin to test if two different types of physical therapy might have different results in children and adolescents who have had a prior stroke, and 2. To determine if either type of physical therapy causes changes in the brain signals that control leg muscles. All participants will receive physical therapy 3 times per week for 8 weeks. Half of the participants will receive typical physical therapy, such as walking practice, muscle strengthening, and balance training. Half of the participants will receive asymmetrical gait training physical therapy, which uses new technology to train each leg differently during walking practice. After enrolling, participants will be randomly assigned to the type of therapy. Measurements will be taken before, during, and after the 8 weeks of physical therapy. These include walking tests to measure symmetry, walking speed and daily step activity, and brain tests to measure the strength of the signals from the brain to the leg muscles. One blood test is also taken to identify if certain genetic factors affect how each child responds to the physical therapy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Conventional physical therapy
  • Behavioral: Asymmetrical gait training
Early Phase 1

Detailed Description

Effective rehabilitation after acquired brain injury is essential for reducing the impact of the leading cause of pediatric disability in the United States. Neuroplastic changes in response to physical therapy are likely different in children compared to adults because children are continuing to experience developmental brain maturation while also experiencing the neural changes associated with injury and rehabilitation. The interaction between these two processes is poorly understood but presumably critical for maximizing long term outcomes. Using biomarkers to measure and predict rehabilitation-induced changes will improve rehabilitation prognosis and will facilitate the development of rehabilitation interventions that optimize neuroplastic potential in children. The objectives of this pilot study are to investigate the motor and neural responses to two different rehabilitation programs in children and adolescents with chronic hemiplegia from prior stroke. Participants will be randomly assigned to receive conventional physical therapy or an asymmetrical gait training program. Conventional physical therapy will include activities such as gait and balance training and muscle strengthening. The asymmetrical gait training program uses new technology to train each leg at a different speed during walking practice. Measurements of motor and neural function will occur at five timepoints before, during and after treatment. Motor function measures will include gait symmetry ratios, walking speed, community step activity, and participant and caregiver ratings on self-identified walking goals. Neural measures will include motor response characteristics of muscle contractions elicited in two lower extremity muscles by transcranial magnetic stimulation of the injured cortex. We will also establish a genetic database to identify the presence or absence of two genetic variants [Apolipoprotein E (ApoE Є4) and val66met Brain-derived neurotropic factor (BDNF) polymorphisms] associated with decreased potential for neuroplasticity for planning future investigations. The results will be used to inform the design of larger studies evaluating physical therapy treatments that maximize the capacity of the child's brain to change after neurological injury and identifying predictors of rehabilitation-induced neuroplasticity in children.

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Motor Outcomes and Neural Correlates of Asymmetrical Gait Training in Children With Acquired Hemiplegia
Study Start Date :
Apr 1, 2013
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional physical therapy

Includes traditional physical treatment, such as gait and balance training and muscle strengthening.

Behavioral: Conventional physical therapy

Active Comparator: Asymmetrical gait training

Includes walking on a split-belt treadmill with the belts moving at different speeds under each leg, alternated with overground walking training.

Behavioral: Asymmetrical gait training

Outcome Measures

Primary Outcome Measures

  1. Change in walking symmetry [before and after 8 weeks of therapy]

Secondary Outcome Measures

  1. Change in walking speed [before and after 8 weeks of therapy]

  2. Change in excitability of neural motor pathways [before and after 8 weeks of therapy]

  3. Change in patient/parent satisfaction rating [before and after 8 weeks of therapy]

  4. Change in community step activity [before and after 8 weeks of therapy]

Other Outcome Measures

  1. Changes in walking ability and cortical excitability measures (detailed above) [before and after a 4 week baseline phase; before and after a 4 week withdraw phase]

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Between 5-17 years of age

  2. History of unilateral supratentorial arterial ischemic or hemorrhagic stroke

  3. Onset of stroke at least 6 months before study enrollment

  4. Ability to walk at least 20 feet without the use of an assistive device

  5. At least a 5 second difference in single leg stance time between left and right sides

  6. The ability to return to the Children's Hospital of Philadelphia (CHOP) for the proposed training and testing sessions

  7. Parental/guardian permission (informed consent) and if appropriate, child assent

Exclusion Criteria:
  1. Intracranial metallic or magnetic object or implanted electrical pacing device

  2. Treatment with botulinum toxin injections to the more affected ankle plantarflexors in the past 3 months

  3. Cognitive impairment that would prevent completion of the required training and testing activities

  4. Parents/guardians or participants who, in the opinion of the investigator, may not adhere with study schedules or procedures

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • Children's Hospital of Philadelphia

Investigators

  • Principal Investigator: Laura A Prosser, PhD, PT, Children's Hospital of Philadelphia

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01827436
Other Study ID Numbers:
  • 12-009844
First Posted:
Apr 9, 2013
Last Update Posted:
Jan 5, 2018
Last Verified:
Jan 1, 2018
Keywords provided by Children's Hospital of Philadelphia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 5, 2018